Health technology assessment and screening in Sweden

被引:11
作者
Jonsson, E
Banta, HD
Scherstén, T
机构
[1] Netherlands Organization for Applied Scientific Research (TNO), SBU
关键词
health technology assessment; screening; mammography; PSA; ultrasound in pregnancy;
D O I
10.1017/S0266462301106094
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To describe health technology assessment (HTA) and policies concerning three screening procedures in Sweden. Methods: The main source of information was reports from the Swedish Council for Technology Assessment in Health Care (SBU) and other governmental reports, supplemented by the professional literature. Results: Prevention is emphasized in the healthcare services of Sweden. Specifically, screening is encouraged and supported when it is deemed beneficial. Sweden has a strong orientation toward evidence-based health care and HTA. Since its inauguration in 1987, SBU has fostered the use of HTA in making policy and clinical decisions in Sweden. Government policy in Sweden is to encourage services that are beneficial and cost-effective and discourages services that are not. Screening is no exception to this general rule. The three cases examined in this paper-mammography screening, PSA screening, and routine ultrasound screening in pregnancy-have all been formally assessed in Sweden. Assessments have been an integral part of policy making concerning these and other preventive measures. Mammography screening has been widely implemented. However, as in other countries, screening is often carried out in an opportunistic fashion, so that PSA screening, in particular, is carried out more in Sweden than can be justified by the evidence. Conclusions: Mammography screening is promoted and is completely available to the target group. PSA screening is discouraged, but not with complete success. Ultrasound in pregnancy is widely used, not because of good evidence of impact on mortality and morbidity among newborns, but because it increases the detection rate of congenitally malformed fetuses and because of evidence of positive effects on the management and planning of deliveries, as well as because of psychological and ethical implications of the technology. HTA is an important part of health policy making in Sweden.
引用
收藏
页码:380 / 388
页数:9
相关论文
共 19 条
[1]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[2]   RANDOMIZED STUDY OF MAMMOGRAPHY SCREENING - PRELIMINARY-REPORT ON MORTALITY IN THE STOCKHOLM TRIAL [J].
FRISELL, J ;
EKLUND, G ;
HELLSTROM, L ;
LIDBRINK, E ;
RUTQVIST, LE ;
SOMELL, A .
BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (01) :49-56
[3]  
JONSSON E, 1995, HLTH CARE TECHNOLOGY, P209
[4]  
Laird N M, 1990, Int J Technol Assess Health Care, V6, P5
[5]  
Larsson L G, 1996, J Med Screen, V3, P129
[6]  
*NAT BOARD HLTH WE, 1990, UPPF KVAL ALLM RAD
[7]  
*NAT BOARD HLTH WE, 1993, MORF DIAGN BROSTC PR
[8]  
*NAT BOARD HLTH WE, 1986, MAMM SCREEN EARL DET
[9]  
*NAT BOARD HLTH WE, 1998, MAMM SCREEN EARL DET
[10]   BREAST-CANCER SCREENING WITH MAMMOGRAPHY - OVERVIEW OF SWEDISH RANDOMIZED TRIALS [J].
NYSTROM, L ;
RUTQVIST, LE ;
WALL, S ;
LINDGREN, A ;
LINDQVIST, M ;
RYDEN, S ;
ANDERSSON, I ;
BJURSTAM, N ;
FAGERBERG, G ;
FRISELL, J ;
TABAR, L ;
LARSSON, LG .
LANCET, 1993, 341 (8851) :973-978